Terms: = Thyroid cancer AND PR, PGR, progesterone receptor AND Prognosis
90 results:
1. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
2. Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway.
Zhang C; Zhou Y; Chen T; Bhushan S; Sun S; Zhang P; Yang Y
Sci Rep; 2024 Feb; 14(1):4732. PubMed ID: 38413708
[TBL] [Abstract] [Full Text] [Related]
3. ER+/PR- phenotype exhibits more aggressive biological features and worse outcome compared with ER+/PR+ phenotype in HER2-negative inflammatory breast cancer.
Luo Y; Li Q; Fang J; Pan C; Zhang L; Xu X; Qian S; Zhao X; Hou L
Sci Rep; 2024 Jan; 14(1):197. PubMed ID: 38167641
[TBL] [Abstract] [Full Text] [Related]
4. Clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
Yin L; Yin AH; Pu CC
BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
[TBL] [Abstract] [Full Text] [Related]
5. Clinical characteristics and prognosis of postpartum breast cancer.
Paik PS; Choi JE; Lee SW; Lee YJ; Kang YJ; Lee HJ; Bae SY;
Breast Cancer Res Treat; 2023 Nov; 202(2):275-286. PubMed ID: 37542632
[TBL] [Abstract] [Full Text] [Related]
6. Primary Ovarian Small Cell Carcinoma of Pulmonary Type: Analysis of 6 Cases and Review of 31 Cases in the Literatures.
Chen X; Liu HL; Wang JS; Zhao FH
Chin Med Sci J; 2023 Jun; 38(2):130-137. PubMed ID: 37286512
[TBL] [Abstract] [Full Text] [Related]
7. Correlation of PKM2 Expression With HER2/neu and Additional Breast cancer Biomarkers and its Prognostic Significance.
Al-Qudah MA; Al-Keilani MS; Obeidat M; Haddad HK; Bdeir R; Samman LM
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):363-370. PubMed ID: 37212690
[TBL] [Abstract] [Full Text] [Related]
8. The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours.
Resteghini C; Castelnuovo P; Nicolai P; Orlandi E; Bossi P; Vischioni B; Schreiber A; Gambazza S; Iacovelli NA; Battaglia P; Guzzo M; Turri-Zanoni M; Mattavelli D; Facchinetti N; Calareso G; Ravanelli M; Facco C; Tartaro T; Licitra L
Eur J Cancer; 2023 Jul; 187():185-194. PubMed ID: 37164774
[TBL] [Abstract] [Full Text] [Related]
9. Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast cancers and thyroid Disease.
Li J; Liu Y; Jin J; Shi Q; Ji Y; Zhang B; Hu P
Mediators Inflamm; 2023; 2023():3133554. PubMed ID: 37152372
[TBL] [Abstract] [Full Text] [Related]
10. The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients.
Hayama S; Nakamura R; Ishige T; Sangai T; Sakakibara M; Fujimoto H; Ishigami E; Masuda T; Nakagawa A; Teranaka R; Ota S; Itoga S; Yamamoto N; Nagashima T; Otsuka M
BMC Cancer; 2023 Apr; 23(1):384. PubMed ID: 37106324
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Features and prognosis Analysis of Hormone receptor-Positive, HER2-Negative Breast cancer with Differential Expression Levels of Estrogen and progesterone receptors: A 10-Year Retrospective Study.
Liu J; Gan M; Lin Z; Deng Q; Deng J; Zeng B; Shi Y; Ming J
Breast J; 2022; 2022():5469163. PubMed ID: 36531979
[TBL] [Abstract] [Full Text] [Related]
12. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis.
Zhang Z; Fang T; Lv Y
World J Surg Oncol; 2022 Nov; 20(1):361. PubMed ID: 36372891
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis.
Qiao L; Ba J; Xie J; Zhu R; Wan Y; Zhang M; Jin Z; Guo Z; Yu J; Chen S; Yao Y
World J Surg Oncol; 2022 Sep; 20(1):316. PubMed ID: 36171591
[TBL] [Abstract] [Full Text] [Related]
15. Circular RNA circPRMT5 is upregulated in breast cancer and is required for cell proliferation and migration.
Li X; Zhang D; Feng Z; Xu X; Zhang J; Yu A; Zhu L; Xiao J; Du J; Chen M
Turk J Med Sci; 2022 Apr; 52(2):303-312. PubMed ID: 36161608
[TBL] [Abstract] [Full Text] [Related]
16. The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score.
Yang ZJ; Liu YX; Huang Y; Chen ZJ; Zhang HZ; Yu Y; Wang X; Cao XC
Cancer Med; 2023 Feb; 12(3):2493-2504. PubMed ID: 35909232
[TBL] [Abstract] [Full Text] [Related]
17. Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC).
Shi L; You Q; Wang J; Wang H; Li S; Tian R; Yao X; Wu W; Zhang L; Wang F; Lin Y; Li S
Endocrine; 2022 Oct; 78(1):68-76. PubMed ID: 35767182
[TBL] [Abstract] [Full Text] [Related]
18. An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic thyroid Carcinoma.
Hatashima A; Archambeau B; Armbruster H; Xu M; Shah M; Konda B; Lott Limbach A; Sukrithan V
Thyroid; 2022 Aug; 32(8):926-936. PubMed ID: 35583228
[No Abstract] [Full Text] [Related]
19. High RRM2 expression has poor prognosis in specific types of breast cancer.
Shi SC; Zhang Y; Wang T
PLoS One; 2022; 17(3):e0265195. PubMed ID: 35290409
[TBL] [Abstract] [Full Text] [Related]
20. Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast cancer.
Min Y; Feng Y; Luo H; Hu D; Wei X; He D; Yin G; Fan S
Front Endocrinol (Lausanne); 2022; 13():824362. PubMed ID: 35250881
[TBL] [Abstract] [Full Text] [Related]
[Next]
